Effect of Gender on Atrial Electrophysiologic Changes Induced by Rapid Atrial Pacing and Elevation of Atrial Pressure by Tse, Hung-Fat et al.
Effect of Gender on Atrial Electrophysiologic Changes Induced
by Rapid Atrial Pacing and Elevation of Atrial Pressure
HUNG-FAT TSE, M.D., HAKAN ORAL, M.D., FRANK PELOSI, M.D.,
BRADLEY P. KNIGHT, M.D., S. ADAM STRICKBERGER, M.D.,
and FRED MORADY, M.D.
From the Department of Internal Medicine, Division of Cardiology, University of Michigan Medical Center, Ann Arbor, Michigan
Atrial Electrical Remodeling. Introduction: The incidence of atrial  brillation is greater in men than
in women, but the reasons for this gender difference are unclear. The purpose of this study was to evaluate
the effects of gender on the atrial electrophysiologic effects of rapid atrial pacing and an increase in atrial
pressure.
Methods and Results: Right atrial pressure and effective refractory period (ERP) were measured during
sinus rhythm and during atrial and simultaneous AV pacing at a cycle length of 300 msec in 10
premenopausal women, 11 postmenopausal women, and 24 men. The postmenopausal women were
signi cantly older than the premenopausal women (61 6 8 years vs 34 6 10 years; P < 0.01). During sinus
rhythm, mean atrial ERP in premenopausal women was shorter (211 6 19 msec) than in postmenopausal
women and age-matched men (242 6 18 msec and 246 6 34 msec, respectively; P < 0.05). Atrial ERPs
in all patients shortened signi cantly during atrial and simultaneous AV pacing. However, the degree of
shortening during atrial pacing (43 6 8 msec vs 70 6 20 msec and 74 6 21 msec; P < 0.05) and during
simultaneous AV pacing (48 6 16 msec vs 91 6 27 msec and 84 6 26 msec; P < 0.05) was signi cantly
less in premenopausal women than in postmenopausal women or age-matched men.
Conclusion: The results of this study demonstrate a signi cant gender difference in atrial electrophysiologic
changes in response to rapid atrial pacing and an increase in atrial pressure. The effect of menopause on
the observed changes suggests that the gender differences may be mediated by the effects of estrogen on
atrial electrophysiologic properties. (J Cardiovasc Electrophysiol, Vol. 12, pp. 986-989, September 2001)
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Introduction
In the Framingham Study, after adjustment for age and
other risk factors, atrial  brillation (AF) occurred 50% more
often in men than in women.1 The reasons for this gender
difference are unclear. An experimental study demonstrated
that 17b-estradiol attenuates the shortening of atrial refrac-
toriness that occurs after rapid atrial pacing.2 A recent
clinical study demonstrated signi cant gender and age dif-
ferences in the behavior of induced AF and in the shortening
of atrial refractoriness after an episode of AF.3 These stud-
ies suggested that estrogen may attenuate atrial electrical
remodeling, thereby decreasing the susceptibility to AF.
However, the relationship between gender and atrial elec-
trophysiologic properties in humans is unclear. Therefore,
the goal of the present study was to evaluate the effects of
gender and menopause on the atrial effects of rapid pacing
and an increase in atrial pressure.
Methods
Subject Characteristics
The present study is a retrospective analysis of the data
obtained in a prior study of atrial mechanoelectrical feed-
back.4 Women who were undergoing hormone replacement
therapy or oral contraceptive therapy or who had undergone
oophorectomy were excluded from the present analysis. In
addition, patients in the prior study in whom the effects of
verapamil were tested were excluded. With these exclusion
criteria, 45 of the 62 subjects in the prior study were
selected for inclusion in the present study.
The study population consisted of 45 patients who un-
derwent radiofrequency catheter ablation of paroxysmal su-
praventricular tachycardia. None of the study subjects had
structural heart disease or a known history of AF. There
were 24 men and 21 women. Among the women, 10 were
premenopausal and 11 were postmenopausal. The criterion
for menopause was amenorrhea for . 12 months, not attrib-
utable to pregnancy. The mean age of the postmenopausal
women (61 6 8 years; mean 6 SD) was signi cantly
greater than the mean age of the premenopausal women
(34 6 10 years; P , 0.01). The male patients were divided
into two subgroups, according to age, such that the mean
ages were matched to the mean ages of the premenopausal
and postmenopausal women. Their clinical characteristics
are summarized in Table 1. The women were signi cantly
shorter than the men. However, there were no signi cant
differences in body weight, body surface area, left ventric-
ular ejection fraction, or left atrial size among the four
groups of subjects.
Electrophysiologic Procedures
The electrophysiologic procedures were performed with
the patient in the fasting state after informed consent was
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obtained. All antiarrhythmic drug therapy was discontinued
at least  ve half-lives before the procedure. Three quadri-
polar electrode catheters were inserted into a femoral vein
and initially positioned in the high right atrium, His-bundle
position, and right ventricular apex. Several ECG leads and
the intracardiac electrograms were displayed on an oscillo-
scope and recorded on optical disk. Pacing was performed
with a programmable stimulator using stimuli that had a
duration of 2 msec.
Study Protocol
The study protocol was approved by the Human Re-
search Committee and was performed upon completion of
the radiofrequency catheter ablation procedure, which was
successful in all patients. The details of the study protocol
were described previously.4 In brief, a quadripolar electrode
catheter was positioned in the right atrial appendage such
that the pacing threshold was , 1.0 mA. Mean atrial pacing
threshold was 0.7 6 0.2 mA. Pacing was performed at 3 3
threshold. Another electrode catheter was positioned at the
right ventricular apex for ventricular pacing. The tip of a
65-cm guiding sheath was positioned in the right atrium to
measure atrial pressure. Mean right atrial pressure and mean
blood pressure were recorded during each measurement of
atrial effective refractory period (ERP).
Atrial ERP was measured during sinus rhythm by intro-
ducing an atrial extrastimulus after every eighth sinus beat
at an initial coupling interval of 150 msec and increasing the
coupling interval in increments of 5 msec until there was
atrial capture. Atrial ERP was de ned as the longest S1-S2
coupling interval that failed to result in atrial capture.
Atrial ERP then was measured during atrial and simul-
taneous AV pacing at a cycle length of 300 msec, in random
order. Simultaneous AV pacing (AV interval 5 0 msec) at
a cycle length of 300 msec was used to evoke an acute
increase in right atrial pressure,4 and right atrial pacing at
the same cycle length was used to control for the effect of
an increase in rate on atrial ERP. After 3 minutes of con-
tinuous pacing at a cycle length of 300 msec, an atrial
extrastimulus was introduced at a coupling interval of 100
msec. After every eighth drive train stimulus, the coupling
interval of the extrastimulus was increased by 5 msec, with
no pause in the drive train, until the extrastimulus resulted
in atrial capture twice in succession.
Statistical Analysis
Continuous variables are expressed as mean 6 1 SD.
Statistical comparisons were performed with Student’s t-
test. Analysis of variance was used for multiple group
comparisons, followed by a Bonferroni-corrected t-test. P ,
0.05 was considered statistically signi cant.
Results
Hemodynamic Changes
During sinus rhythm, mean right atrial pressure in pre-
menopausal women, postmenopausal women, and age-
matched men did not differ signi cantly (Table 2). Mean
right atrial pressure during atrial pacing at a cycle length of
300 msec also did not differ signi cantly among the four
groups of patients (Table 2).
During simultaneous AV pacing at a cycle length of 300
msec, mean right atrial pressure increased signi cantly
compared with during sinus rhythm and atrial pacing, and it
increased to a similar degree in the premenopausal women,
postmenopausal women, and age-matched men (Table 2).
TABLE 1
Clinical Characteristics
Premenopausal Women Young Men Postmenopausal Women Elderly Men
No. 10 12 11 12
Age (years) 34 6 10 36 6 16 61 6 8 60 6 9
Height (cm) 163 6 14* 176 6 16 160 6 25* 177 6 13
Weight (kg) 80 6 30 83 6 18 78 6 23 82 6 12
Body surface area (m2) 1.9 6 0.3 2.0 6 0.2 1.8 6 0.2 2.0 6 0.3
Left ventricular ejection fraction 0.61 6 0.03 0.63 6 0.04 0.62 6 0.02 0.62 6 0.03
Left atrial size (cm) 3.4 6 0.4 3.6 6 0.3 3.5 6 0.5 3.7 6 0.2
Variables are expressed as mean 6 1 SD.










(n 5 12) P Value
Mean right atrial pressure (mmHg)
Sinus rhythm 2.1 6 2.6* 3.2 6 2.8* 3.2 6 3.0* 2.8 6 2.9* . 0.05
Atrial pacing 4.1 6 3.3* 5.3 6 3.7* 4.2 6 2.5* 4.1 6 2.4* . 0.05
AV pacing 9.6 6 3.2 11.3 6 3.6 10.2 6 3.5 11.3 6 2.7 . 0.05
Mean changes in right atrial pressure (mmHg)†
Atrial pacing 2.0 6 2.5* 2.1 6 3.0* 1.1 6 1.9* 1.3 6 2.1* . 0.05
AV pacing 6.1 6 2.5 6.6 6 2.2 8.1 6 2.3 8.5 6 1.9 . 0.05
Variables are expressed as mean 6 1 SD.
*P , 0.05 vs pacing.
†Changes in pressure compared with sinus rhythm.
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Atrial Refractoriness
There were no signi cant differences in mean sinus cycle
length among premenopausal women, postmenopausal
women, and age-matched men (Table 3). During sinus
rhythm, atrial ERP in premenopausal women was signi -
cantly shorter than in postmenopausal women and than in
both groups of men (Table 3).
Compared with during sinus rhythm, mean atrial ERP
shortened signi cantly during atrial pacing (P , 0.01), with
a further shortening during simultaneous AV pacing in
postmenopausal women and men (P , 0.01; Table 3). In
premenopausal women, mean atrial ERP decreased signi -
cantly during atrial pacing, with no further signi cant
change during simultaneous AV pacing (Table 3).
Menopausal Status
The degree of shortening of atrial ERP during atrial and
simultaneous AV pacing was signi cantly smaller in pre-
menopausal women than in postmenopausal women or in
age-matched men (Table 3).
Effect of Age and Height
Changes in atrial ERP in response to atrial and simulta-
neous AV pacing were similar in magnitude between the
younger and older men (Table 3). Despite the signi cant
difference in height between the postmenopausal women
and the age-matched men, there were no signi cant differ-
ences in the changes in atrial ERP in response to atrial or
simultaneous AV pacing (Table 3).
Discussion
Main Findings
The results of this study indicate that atrial ERP and the
response of the atrial ERP to tachycardia and an increase in
atrial pressure in women are in uenced by menopausal
status. In premenopausal women, baseline atrial refractori-
ness is shorter than in postmenopausal women. Further-
more, the degree of shortening in ERP that occurs during
rapid atrial pacing and the elevation of atrial pressure is
smaller in magnitude in premenopausal women than in
postmenopausal women. If the differences between pre-
menopausal and postmenopausal women were attributable
simply to the difference in age between the two groups of
women, age-dependent differences in atrial ERP also would
be expected in men. However, there were no age-dependent
differences in atrial ERP among the men, and changes in
atrial ERP in response to tachycardia and elevated atrial
pressure in the men did not differ signi cantly from the
postmenopausal women.
These  ndings suggest that the differences in atrial elec-
trophysiologic characteristics between the premenopausal
and postmenopausal women may be attributable to hor-
mones such as estrogen. It is possible that the attenuated
shortening of atrial ERP in response to tachycardia and an
elevated atrial pressure observed in premenopausal women
contributes to the gender difference in the incidence of AF.
Prior Studies
Prior experimental studies demonstrated that 17b-estra-
diol shortens the action potential duration in atrial myocytes
without signi cantly affecting the resting membrane poten-
tial.5 ,6 In the present study, the shorter baseline atrial ERP in
premenopausal women than in postmenopausal women or
in age-matched men is consistent with this  nding. How-
ever, another experimental study reported that atrial refrac-
toriness prolonged after 17b-estradiol administration.2 The
reason for this discrepancy is unclear but may be related to
the use of a supraphysiologic dosage of 17b-estradiol in the
latter study.
Pretreatment with 17b-estradiol in dogs was found to
prevent the shortening of atrial refractoriness that otherwise
occurs after rapid atrial pacing.2 A recent clinical study
found that the shortening in atrial ERP that occurs after an
episode of AF is lesser in magnitude in women than in
men.3 The results of the present study are consistent with
these  ndings.
Possible Mechanisms
Experimental studies demonstrated that 17b-estradiol
suppresses the expression of L-type calcium channels and
inhibits the L-type calcium current.6 -8 The resultant reduc-
tion in the plateau phase of the atrial action potential might
explain why the baseline atrial ERP in the present study was
found to be shorter in premenopausal women than in post-
menopausal women or in men.
Prior studies in humans9 ,10 and animals1 1 ,12 demonstrated
that tachycardia-induced shortening of atrial refractoriness
is related to intracellular calcium overload and reduction in
calcium current. Furthermore, recent clinical4 and experi-
TABLE 3








(n 5 12) P Value
Sinus cycle length (msec) 859 6 120 790 6 150 890 6 113 802 6 124 . 0.05
Mean ERP (msec)
Sinus rhythm 211 6 19*,† 246 6 34*,† 242 6 17*,† 240 6 12*,† , 0.05
Atrial pacing 169 6 18* 171 6 24* 172 6 19* 173 6 19* . 0.05
AV pacing 163 6 20 162 6 26 151 6 25 149 6 28 . 0.05
Mean changes in ERP msec‡
Atrial pacing 43 6 8 74 6 21* 70 6 20* 68 6 19* , 0.05
AV pacing 48 6 16 84 6 26 91 6 27 92 6 30 , 0.05
Variables are expressed as mean 6 1 SD. ERP 5 effective refractory period.
*P , 0.05 vs AV pacing; †P , 0.05 vs atrial pacing.
†Changes in pressure compared with sinus rhythm.
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mental1 3 studies showed that calcium channel blockade with
verapamil attenuates the shortening of atrial refractoriness
that occurs in response to an increase in atrial pressure. It is
possible that the calcium channel-blocking properties that
estrogen may have in common with verapamil explain the
attenuated effects of tachycardia and elevated atrial pressure
on atrial refractoriness in the premenopausal women in the
present study.
Estrogen also was demonstrated to block the delayed
outward potassium current (IKr and IKs),5 ,6 providing an-
other possible mechanism for the blunted response of atrial
ERP due to tachycardia and elevated atrial pressure in
premenopausal women.
Study Limitations
One limitation of this study is that the estrogen plasma
concentrations in the premenopausal women may have var-
ied signi cantly, depending on the timing of the electro-
physiologic procedure relative to the menstrual cycle. Fur-
thermore, the retrospective nature of the analysis did not
allow measurement of plasma estrogen concentrations.
Another limitation is that all the patients in this study had
a history of paroxysmal supraventricular tachycardia and
had undergone radiofrequency ablation; therefore, the  nd-
ings may not apply to normal individuals. Finally, the
sample size of this study was small, and the results require
con rmation in a larger study.
Conclusion
There is a signi cant gender difference in atrial electro-
physiologic characteristics that is manifest only in premeno-
pausal women, suggesting that the gender difference may be
attributable to estrogen. The effects of estrogen on atrial
electrophysiologic characteristics may help to explain the
lower incidence of AF among young women. Further stud-
ies are needed to clarify the relationship between estrogen
and the susceptibility to AF and to determine whether
hormone replacement therapy affects the incidence of AF in
postmenopausal women.
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